Emergence of oral and locomotor activity in chronic haloperidol-treated rats following cortical N-methyl-D-aspartate stimulation
- PMID: 9610939
- DOI: 10.1016/s0091-3057(97)00587-x
Emergence of oral and locomotor activity in chronic haloperidol-treated rats following cortical N-methyl-D-aspartate stimulation
Abstract
Neuroleptic-induced orofacial movements in rats have been widely utilized as an animal model of tardive dyskinesia (TD). The present study investigated the role of the oral motor cortex in these movements by applying direct cortical stimulation in rats exposed to chronic haloperidol. Rats received depot i.m. injections of haloperidol decanoate or sesame oil vehicle every 3 weeks (10 rats per group). After 24 weeks of injections and a 3-week withdrawal period, bilateral guide cannulae were implanted into the primary oral motor cortex. After a 1-week recovery, bilateral microinfusions of saline vehicle followed by 1, 3, and 10 mM N-methyl-D-aspartate (NMDA) were given and observations of oral activity, locomotion, rearing, and grooming were recorded. Haloperidol-treated rats displayed a significant emergence of NMDA stimulated oral activity (nondirected oral movements, oral tremor, audible teeth grinding, and directed oral movements). In addition, rearing and locomotion were significantly elevated in these animals. In contrast to haloperidol-treated rats, sesame oil-treated rats showed no significant emergence of any motor activity. These results suggest that chronic haloperidol administration alters primary motor cortex efferents, and that this effect may be a factor in the manifestation of chronic neuroleptic induced motor side effects, such as TD.
Similar articles
-
Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats.Pak J Pharm Sci. 2013 Mar;26(2):271-6. Pak J Pharm Sci. 2013. PMID: 23455196
-
Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.Prog Neuropsychopharmacol Biol Psychiatry. 2008 Aug 1;32(6):1473-8. doi: 10.1016/j.pnpbp.2008.05.003. Epub 2008 May 11. Prog Neuropsychopharmacol Biol Psychiatry. 2008. PMID: 18554768
-
Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.Pharmacol Biochem Behav. 2008 Feb;88(4):511-22. doi: 10.1016/j.pbb.2007.10.009. Epub 2007 Oct 25. Pharmacol Biochem Behav. 2008. PMID: 18022680
-
Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia.Psychopharmacology (Berl). 1990;101(4):431-47. doi: 10.1007/BF02244220. Psychopharmacology (Berl). 1990. PMID: 1975104 Review.
-
Quantification of motor function in toxicology.Toxicol Lett. 1988 Oct;43(1-3):295-319. doi: 10.1016/0378-4274(88)90035-5. Toxicol Lett. 1988. PMID: 3140429 Review.
Cited by
-
Early suppression of striatal cyclic GMP may predetermine the induction and severity of chronic haloperidol-induced vacous chewing movements.Metab Brain Dis. 2000 Dec;15(4):275-85. doi: 10.1023/a:1011171124603. Metab Brain Dis. 2000. PMID: 11383552
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources